Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Enanta Pharmaceuticals is a biotechnology company specializing in the discovery and development of small molecule drugs targeting virology and immunology. Its core focus includes antiviral agents for hepatitis C, RSV, SARS-CoV-2, and hepatitis B, as well as immunology treatments for inflammatory diseases like chronic urticaria and atopic dermatitis. The company leverages chemistry-driven research, collaborates with partners like AbbVie, and aims to address significant unmet medical needs through innovative therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.